Factors associated with initiation and persistence of urate-lowering therapy

BACKGROUND: Gout is the most common inflammatory arthritic disease and is caused by crystal deposition secondary to persistent hyperuricemia. Etiological treatment with urate-lowering therapy (ULT) has been available since the 1950s but previous studies have demonstrated suboptimal degree of treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehlin, Mats, Ekström, Emin Hoxha, Petzold, Max, Strömberg, Ulf, Telg, Gunilla, Jacobsson, Lennart T. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240247/
https://www.ncbi.nlm.nih.gov/pubmed/28095891
http://dx.doi.org/10.1186/s13075-016-1211-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240247/
https://www.ncbi.nlm.nih.gov/pubmed/28095891
http://dx.doi.org/10.1186/s13075-016-1211-y

Ejemplares similares